{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:27:03Z","timestamp":1761989223059,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12253-015-0007-8","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T21:45:19Z","timestamp":1447883119000},"page":"413-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Increased Expression of Phosphatidylinositol 3-Kinase p110\u03b1 and Gene Amplification of PIK3CA in Nasopharyngeal Carcinoma"],"prefix":"10.1007","volume":"22","author":[{"given":"Wai Kien","family":"Yip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maizaton Atmadini","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suryati","family":"Yusoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng Fong","family":"Seow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"issue":"50","key":"7_CR1","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","volume":"24","author":"DA Altomare","year":"2005","unstructured":"Altomare DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24(50):7455\u20137464","journal-title":"Oncogene"},{"issue":"7","key":"7_CR2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2(7):489\u2013501","journal-title":"Nat Rev Cancer"},{"key":"7_CR3","first-page":"281","volume":"5","author":"MA Bruhn","year":"2013","unstructured":"Bruhn MA, Pearson RB, Hannan RD, Sheppard KE (2013) AKT-independent PI3-K signaling in cancer - emerging role for SGK3. Cancer Manag Res 5:281\u2013292","journal-title":"Cancer Manag Res"},{"key":"7_CR4","first-page":"21","volume":"347","author":"Y Samuels","year":"2010","unstructured":"Samuels Y, Waldman T (2010) Oncogenic mutations of PIK3CA in human cancers. Curr Top Microbiol Immunol 347:21\u201341","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"7_CR5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.0408864102","volume":"102","author":"S Kang","year":"2005","unstructured":"Kang S, Bader AG, Vogt PK (2005) Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci U S A 102(3):802\u2013807","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR6","doi-asserted-by":"crossref","unstructured":"Samuels Y, Diaz Jr LA, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I, Rago C, Huso DL, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7(6):561\u2013573","DOI":"10.1016\/j.ccr.2005.05.014"},{"issue":"8","key":"7_CR7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9(8):550\u2013562","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"7_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","volume":"21","author":"L Shayesteh","year":"1999","unstructured":"Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21(1):99\u2013102","journal-title":"Nat Genet"},{"issue":"5","key":"7_CR9","doi-asserted-by":"crossref","first-page":"R609","DOI":"10.1186\/bcr1262","volume":"7","author":"G Wu","year":"2005","unstructured":"Wu G, Xing M, Mambo E, Huang X, Liu J, Guo Z, Chatterjee A, Goldenberg D, Gollin SM, Sukumar S, Trink B, Sidransky D (2005) Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Res 7(5):R609\u2013R616","journal-title":"Breast Cancer Res"},{"issue":"8","key":"7_CR10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/ijc.21461","volume":"118","author":"BI Bertelsen","year":"2006","unstructured":"Bertelsen BI, Steine SJ, Sandvei R, Molven A, Laerum OD (2006) Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation. Int J Cancer 118(8):1877\u20131883","journal-title":"Int J Cancer"},{"issue":"10","key":"7_CR11","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","volume":"15","author":"ET Chang","year":"2006","unstructured":"Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev 15(10):1765\u20131777","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"7_CR12","first-page":"319","volume":"19","author":"WK Yip","year":"2008","unstructured":"Yip WK, Leong VC, Abdullah MA, Yusoff S, Seow HF (2008) Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma. Oncol Rep 19(2):319\u2013328","journal-title":"Oncol Rep"},{"issue":"2","key":"7_CR13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2011.12.018","volume":"318","author":"WK Yip","year":"2012","unstructured":"Yip WK, Seow HF (2012) Activation of phosphatidylinositol 3-kinase\/Akt signaling by EGF downregulates membranous E-cadherin and beta-catenin and enhances invasion in nasopharyngeal carcinoma cells. Cancer Lett 318(2):162\u2013172","journal-title":"Cancer Lett"},{"issue":"3","key":"7_CR14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12032-008-9124-5","volume":"26","author":"CC Chou","year":"2009","unstructured":"Chou CC, Chou MJ, Tzen CY (2009) PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival. Med Oncol 26(3):322\u2013326","journal-title":"Med Oncol"},{"issue":"1","key":"7_CR15","first-page":"15","volume":"26","author":"P Liu","year":"2007","unstructured":"Liu P, Li DJ, Qin HD, Zhang RH, Chen LZ, Zeng YX (2007) Screening for mutations in the hotspot mutation regions of PIK3CA gene in nasopharyngeal carcinoma. Ai Zheng 26(1):15\u201320","journal-title":"Ai Zheng"},{"issue":"4","key":"7_CR16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ijc.21444","volume":"118","author":"YY Or","year":"2006","unstructured":"Or YY, Hui AB, To KF, Lam CN, Lo KW (2006) PIK3CA mutations in nasopharyngeal carcinoma. Int J Cancer 118(4):1065\u20131067","journal-title":"Int J Cancer"},{"issue":"11","key":"7_CR17","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1349-7006.2009.01292.x","volume":"100","author":"A Fendri","year":"2009","unstructured":"Fendri A, Khabir A, Mnejja W, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R (2009) PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma. Cancer Sci 100(11):2034\u20132039","journal-title":"Cancer Sci"},{"issue":"5","key":"7_CR18","volume":"7","author":"C Mao","year":"2012","unstructured":"Mao C, Zhou J, Yang Z, Huang Y, Wu X, Shen H, Tang J, Chen Q (2012) KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer. PLoS One 7(5):e36653","journal-title":"PLoS One"},{"issue":"10","key":"7_CR19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/apm.12152","volume":"121","author":"WK Yip","year":"2013","unstructured":"Yip WK, Choo CW, Leong VC, Leong PP, Jabar MF, Seow HF (2013) Molecular alterations of ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia. APMIS 121(10):954\u2013966","journal-title":"APMIS"},{"issue":"4","key":"7_CR20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-06-1125","volume":"13","author":"P Hou","year":"2007","unstructured":"Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M (2007) Genetic alterations and their relationship in the phosphatidylinositol 3-kinase\/Akt pathway in thyroid cancer. Clin Cancer Res 13(4):1161\u20131170","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7_CR21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-009-0508-9","volume":"122","author":"MA Aleskandarany","year":"2010","unstructured":"Aleskandarany MA, Rakha EA, Ahmed MA, Powe DG, Paish EC, Macmillan RD, Ellis IO, Green AR (2010) PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis. Breast Cancer Res Treat 122(1):45\u201353","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.2601","volume":"219","author":"Z Jehan","year":"2009","unstructured":"Jehan Z, Bavi P, Sultana M, Abubaker J, Bu R, Hussain A, Alsbeih G, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S, Al-Kuraya KS (2009) Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. J Pathol 219(3):337\u2013346","journal-title":"J Pathol"},{"issue":"3","key":"7_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.1207","volume":"198","author":"J Woenckhaus","year":"2002","unstructured":"Woenckhaus J, Steger K, Werner E, Fenic I, Gamerdinger U, Dreyer T, Stahl U (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198(3):335\u2013342","journal-title":"J Pathol"},{"issue":"3","key":"7_CR24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3892\/ijo_00000202","volume":"34","author":"I Akagi","year":"2009","unstructured":"Akagi I, Miyashita M, Makino H, Nomura T, Hagiwara N, Takahashi K, Cho K, Mishima T, Ishibashi O, Ushijima T, Takizawa T, Tajiri T (2009) Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma. Int J Oncol 34(3):767\u2013775","journal-title":"Int J Oncol"},{"key":"7_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1476-4598-8-51","volume":"8","author":"J Abubaker","year":"2009","unstructured":"Abubaker J, Bavi P, Al-Haqawi W, Jehan Z, Munkarah A, Uddin S, Al-Kuraya KS (2009) PIK3CA alterations in middle eastern ovarian cancers. Mol Cancer 8:51","journal-title":"Mol Cancer"},{"issue":"4","key":"7_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00428-006-0358-3","volume":"450","author":"J Woenckhaus","year":"2007","unstructured":"Woenckhaus J, Steger K, Sturm K, Munstedt K, Franke FE, Fenic I (2007) Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer. Virchows Arch 450(4):387\u2013395","journal-title":"Virchows Arch"},{"issue":"1","key":"7_CR27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/ERC-08-0167","volume":"16","author":"Y Lin","year":"2009","unstructured":"Lin Y, Jiang X, Shen Y, Li M, Ma H, Xing M, Lu Y (2009) Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors. Endocr Relat Cancer 16(1):301\u2013310","journal-title":"Endocr Relat Cancer"},{"issue":"25","key":"7_CR28","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/onc.2009.81","volume":"28","author":"A Astanehe","year":"2009","unstructured":"Astanehe A, Finkbeiner MR, Hojabrpour P, To K, Fotovati A, Shadeo A, Stratford AL, Lam WL, Berquin IM, Duronio V, Dunn SE (2009) The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1. Oncogene 28(25):2406\u20132418","journal-title":"Oncogene"},{"issue":"3","key":"7_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tibs.2009.01.003","volume":"34","author":"K Kok","year":"2009","unstructured":"Kok K, Geering B, Vanhaesebroeck B (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 34(3):115\u2013127","journal-title":"Trends Biochem Sci"},{"issue":"7","key":"7_CR30","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1158\/1535-7163.MCT-11-0996","volume":"11","author":"CP Carden","year":"2012","unstructured":"Carden CP, Stewart A, Thavasu P, Kipps E, Pope L, Crespo M, Miranda S, Attard G, Garrett MD, Clarke PA, Workman P, de Bono JS, Gore M, Kaye SB, Banerji U (2012) The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer. Mol Cancer Ther 11(7):1609\u20131617","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"7_CR31","first-page":"253","volume":"18","author":"I Fenic","year":"2007","unstructured":"Fenic I, Steger K, Gruber C, Arens C, Woenckhaus J (2007) Analysis of PIK3CA and Akt\/protein kinase B in head and neck squamous cell carcinoma. Oncol Rep 18(1):253\u2013259","journal-title":"Oncol Rep"},{"key":"7_CR32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-12-50","volume":"12","author":"J Shi","year":"2012","unstructured":"Shi J, Yao D, Liu W, Wang N, Lv H, Zhang G, Ji M, Xu L, He N, Shi B, Hou P (2012) Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer. BMC Cancer 12:50","journal-title":"BMC Cancer"},{"issue":"4","key":"7_CR33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molcel.2014.09.023","volume":"56","author":"JA Gasser","year":"2014","unstructured":"Gasser JA, Inuzuka H, Lau AW, Wei W, Beroukhim R, Toker A (2014) SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. Mol Cell 56(4):595\u2013607","journal-title":"Mol Cell"},{"key":"7_CR34","unstructured":"Liu T, Sun Q, Li Q, Yang H, Zhang Y, Wang R, Lin X, Xiao D, Yuan Y, Chen L, Wang W (2014) Dual PI3K\/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma. Mol Cancer Ther 14. doi: 10.1158\/1535-7163.MCT-1114-0548"},{"issue":"3","key":"7_CR35","volume":"8","author":"F Yang","year":"2013","unstructured":"Yang F, Qian XJ, Qin W, Deng R, Wu XQ, Qin J, Feng GK, Zhu XF (2013) Dual phosphoinositide 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma. PLoS One 8(3):e59879","journal-title":"PLoS One"},{"issue":"2","key":"7_CR36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3892\/or.2014.3220","volume":"32","author":"H Jiang","year":"2014","unstructured":"Jiang H, Gao M, Shen Z, Luo B, Li R, Jiang X, Ding R, Ha Y, Wang Z, Jie W (2014) Blocking PI3K\/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition. Oncol Rep 32(2):559\u2013566","journal-title":"Oncol Rep"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-015-0007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-015-0007-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-015-0007-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T17:42:49Z","timestamp":1567359769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-015-0007-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s12253-015-0007-8","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"type":"print","value":"1219-4956"},{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2015,11,18]]}}}